Yüklüyor......

MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic targets in AD. Previously, using senescence-accelera...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antioxidants (Basel)
Asıl Yazarlar: Muraleva, Natalia A., Kolosova, Nataliya G., Stefanova, Natalia A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300733/
https://ncbi.nlm.nih.gov/pubmed/34208998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10071058
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!